Cite
HARVARD Citation
Bhagawati-Prasad, V. et al. (n.d.). 68 An audit of the use of first-line EGFR TKI treatment in NSCLC patients with EGFR activating mutations at the York Teaching Hospitals and Harrogate and District NHS Foundation Trust. Lung cancer. pp. S24-S25. [Online].